Webinars
Targeted Protein Degraders: Through the Lens of the Innovation, Developability, and CMC Challenges
Summary: In this webinar, experts review the trends and challenges associated with the rational design of targeted protein degrader drugs.
View Now
Offering Fact Sheet
ProteoSuite℠ Oral
Summary: Comprehensive toolkit that offers a developability assessment specific to protein degraders.
View Now
Webinars
Small Molecule Testing: Expectations, Assessment & Strategies
Summary: Watch this webinar to explore risk-based approaches to reduce the burden of analytical testing without compromising patient safety.
View Now
Video
CDMO Perspective on Partnering with Clients from Phase I through Commercialization
Summary: During this webinar, experts present the principles, mechanisms and several downstream applications of patented twin-screw granulation technique for oral solid dosage forms.
View Now
Webinars
Twin-Screw Granulation as a Viable Pharmaceutical Process in the Shifting Manufacturing Paradigm
Summary: During this webinar, experts present the principles, mechanisms and several downstream applications of patented twin-screw granulation technique for oral solid dosage forms.
View Now
Webinars
Tackling Bioavailability Challenges for the Next Generation of Small Molecules
Summary: In this webinar, speakers will share industry insights into small molecule drug development advancements and discuss innovative, scalable drug delivery technologies proven to address the industry’s growing need for improving solubility and enhancing bioavailability.
View Now
Webinars
Small Molecule Orphan Drugs: Status Quo, Challenges, and Perspectives
Summary: In this webinar, experts discuss the key drivers and challenges of orphan drug development and manufacturing.
View Now
Executive Summary
Better Decisions for Phase 1 Clinical Trials Using Integrated Design Models
Summary: Learn how innovative trial designs, on-demand manufacturing, real-time clinical data-based dose adjustments, and partnering with experienced formulators and Contract Research Organizations (CROs) can enable faster, better decision making during phase 1 clinical trials.
View Now
Article
Current State & Challenges of Phase 1 Oral Small Molecule Drug Development & Outsourcing
Summary: A recent survey explored the attitudes and changing perceptions of experienced Phase 1 development professionals toward development challenges and available solutions.
View Now
Webinars
Webinar: ADC’s Are Back Stronger Than Ever: How, Why & What’s Next
Summary: Mike Riley, President, Catalent Biologics, will discuss the latest trends in ADC discovery and development, with a focus on how next generation pipelines are being shaped by payload and linker chemistry innovations, including those from Catalent’s award-winning SMARTag® ADC platform.
View Now